0.5 to 2 m
BCI-1. ) = 0 BCI-2. = 0 BCI-3. = 0 BCI-4. = 0 and = 0 implies that BCI-5. 0= 0, for all
5
SYNTHESIS AND ANTI DIABETIC ACTIVITY OF SOME NEW 2-(SUBSTITUTED PHENYL)-4H-CHROMEN-4-ONE DERIVATIVES
6
EC E -5 2 0 C o n t r o l S y s t e m
5
���� � ���� � 0, � ٠(5)
5
Die funksie van die skeppingstradisie in Jeremia 5:20–29
14
The evolution of post starburst galaxies from z=2 to 0 5
15
The evolution of post starburst galaxies from z=2 to 0 5
13
Enaminonitrile derivatives as corrosion inhibitors for Cu10Ni alloy in 0 5 M HCl solutions
11
Cyclic Voltametric Behavior of Iron in 0-2 M HNO3 Solutions
13
Electrochemical and Quantum Chemical Studies of 5 Substituted Tetrazoles as Corrosion Inhibitors for Copper in Aerated 0 5 M H2SO4 Solution
11
Volumetric properties of aqueous solutions of sodium cyclamate in presence of (0 1, 0 3, and 0 5) m fructose at different temperatures
6
On Solutions to the Diophantine Equation M^x+ (M + 6)^y = z^2 when M = 6N + 5
8
Meshless detection of an internal moving boundary
9
2,3 Bis(2 methoxyphenyl)tetrazolium 5 thiolate–acetone–dichloromethane (1/0 4/0 1)
8
Bis[2 (benzimidazol 2 yl)phenolato]zinc(II)–[2 (benzimidazol 2 yl)phenolato][2 (benzimidazol 2 yl) 4 bromophenolato]zinc(II)–ethanol–water (0 67/0 33/2/0 5)
11
Note on Transportation Problem with New Method for Resolution of Degeneracy
11
Effect of Cu2+ Doping on Structural and Optical Properties of Synthetic Zn0 5CuxMg0 5 xFe2O4 (x = 0 0, 0 1, 0 2, 0 3, 0 4) Nano Ferrites
10
Bis[2 (benzimidazol 2 yl)phenolato κ2N,O]zinc(II)–bis[5 amino 2 (benzimidazol 2 yl)phenolato κ2N,O]zinc(II)–ethanol–water (0 56/0 44/2/0 5)
11
Shape Memory Behavior of Ti 22Nb (0 5 2 0)O(at%) Biomedical Alloys
6
Prague Dependency Treebank 2 5 – a Revisited Version of PDT 2 0
16